Gapping up
In reaction to strong earnings/guidance:
- TRVG +15.7%, ZIXI +10.5%, USNA +5.8% (also announces buyback plan), TER +4.8%, VAR +4.5%, UMC +4.5%, BA +4.3%, RRC +4.1%, LRN +3.9% (light volume), ALXN +3.3%, CNI +2.9% (also announces new normal course issuer bid for share repurchase of up to 5.5 mln common shares), COF +2.8%, SEIC +2.5%, BXMT +2.3%, BCS +2%, NOC +1.9%, TMO +1.4%, AMP +0.8%
Other news:
- CMTA +27.7% (plans to submit New Drug Application for palovarotene for the treatment of FOP based on positive phase 2 results)
- LIQT +16.7% (schedules investor update call on tomorrow October 24 at 10am ET)
- TSLA +2.5% (after making notable move higher on Citron report)
- CMP +2% (following today's 20% move lower on guidance)
- PTI +2% (prices 11 mln shares of common stock at $6.75 per share)
- KMX +1.4% (approves $2 bln expansion of share repurchase program)
- TGA +1% (provides operations update)
- SBLK +0.8% (announces termination of debt restructuring restrictions and provides $625 mln financing update), .
Analyst comments:
- CRBP +5.7% (initiated with a Buy at B. Riley FBR; tgt $22)
- NEO +3.9% (upgraded to Strong Buy at First Analysis Sec)
- SM +3.2% (upgraded to Outperform at Wells Fargo)
- DDD +3.2% (upgraded to Neutral from Underweight at Piper Jaffray)
- LMT +2.4% (added to Conviction Buy List at Goldman)
- LULU +1.9% (upgraded to Buy from Hold at Canaccord Genuity)
- AVY +1.2% (upgraded to Overweight from Neutral at JP Morgan)
- VFC +1% (added to Focus List at JP Morgan)
- PHM +0.8% (upgraded to Neutral from Sell at BTIG Research)
![]()